Biotin contributes to normal hair and skin, but the clinical evidence for megadose use in replete adults is thin. Here's what the data actually supports.
From this read
Biotin is the most-purchased hair and skin supplement in the UK, yet the clinical evidence for it in people without a deficiency is surprisingly thin. The authorised claim is real, biotin contributes to the maintenance of normal hair and normal skin [GB-NHC], but "normal maintenance" and "fixing thinning hair" are not the same thing. Here's what the data actually supports.
What the evidence actually shows
I'll be straight with you: the published literature on biotin for hair and skin in otherwise healthy adults is mostly case reports and small observational studies. There are no large RCTs in non-deficient populations showing dramatic regrowth. That's not a reason to dismiss biotin entirely, it's a reason to be precise about what you're expecting from it.
The most cited review, Patel et al. (2020), examined 18 reported cases of biotin supplementation for hair loss and found that in every single case where biotin produced a measurable response, the patient had an underlying cause of biotin deficiency, whether from biotinidase deficiency, pregnancy, or prolonged use of certain medications. In otherwise replete individuals, the evidence for hair regrowth is essentially absent.
Lipner (2018) made a similar point in a review of biotin for hair, nail, and skin conditions: the positive case studies are almost exclusively in patients with low baseline biotin status. She noted that serum biotin levels are rarely measured before supplementation is prescribed, which makes interpreting outcomes nearly impossible.
Where I find the evidence more credible is in the deficiency context. Trüeb (2016) measured serum biotin in 541 women presenting with hair loss complaints and found that 38% had low biotin levels, many without obvious dietary cause. That's not a trivial proportion. If your biotin status is genuinely low, supplementing to restore normal levels is a reasonable intervention. The problem is that most people supplementing have no idea what their serum levels are.
The biology: why biotin matters for hair and skin
Biotin, also called vitamin B7 or vitamin H, is a water-soluble B vitamin that acts as a cofactor for five carboxylase enzymes. These enzymes are involved in fatty acid synthesis, gluconeogenesis, and amino acid catabolism. The link to hair and skin is indirect but mechanistically coherent.
Keratin, the structural protein that makes up roughly 95% of the hair shaft and a significant portion of the skin's barrier layer, is synthesised via pathways that depend on adequate fatty acid production. Fatty acid synthesis requires acetyl-CoA carboxylase, a biotin-dependent enzyme. When biotin is insufficient, fatty acid synthesis is impaired, and keratin production can suffer as a downstream consequence.
Skin barrier function also depends on ceramide synthesis, which involves fatty acids. So biotin deficiency can manifest as dry, flaking skin, not because biotin directly "feeds" skin cells, but because the enzymatic machinery that produces the lipids skin needs is running below capacity.
This is why the GB-NHC authorised wording is carefully worded: biotin contributes to the maintenance of normal hair and normal skin. The claim is about maintaining physiological function when status is adequate, not about producing supraphysiological effects in people who are already replete.
For a broader look at how micronutrient status interacts with hormonal and metabolic function, the hormonal health hub covers the endocrine picture in more depth.
Dosing: what the clinical evidence supports
The reference nutrient intake (RNI) for biotin in the UK is around 30, 40 mcg/day for adults. Most food sources, eggs, liver, nuts, legumes, provide this without difficulty in a varied diet. Deficiency from diet alone is uncommon.
The doses used in the positive case reports reviewed by Patel et al. (2020) ranged from 1,000 mcg to 10,000 mcg (1, 10 mg) per day, doses far above dietary reference values. These were all in patients with confirmed or suspected deficiency states. There is no published RCT in healthy, biotin-replete adults that supports megadose biotin for cosmetic hair or skin outcomes.
The KōJō Daily Formula includes 100 mcg of D-Biotin, the biologically active form. That dose sits comfortably above the RNI and is sufficient to support normal physiological function without approaching the high doses that have been associated with laboratory test interference (more on that below). I chose 100 mcg deliberately: it's enough to cover genuine dietary shortfalls without tipping into the territory where the evidence gets murky.
Shing et al. (2025) published a review of hair, skin, and nail supplements in older adults and noted that while biotin is generally safe across a wide dosing range, high-dose supplementation (above 5,000 mcg/day) has been associated with interference with troponin immunoassays, thyroid function tests, and other biotin-streptavidin-based laboratory tests. The clinical risk is real enough that the FDA issued a safety communication about it. At 100 mcg, this isn't a concern, but if you're taking a supplement containing 5,000, 10,000 mcg and you're going in for blood tests, flag it to whoever's taking your blood.
Who actually benefits: the deficiency question
The honest answer is that biotin supplementation is most likely to produce a noticeable difference in people who have suboptimal biotin status to begin with. The groups at higher risk of low biotin include:
- People with biotinidase deficiency (a rare genetic condition affecting biotin recycling)
- Pregnant women, biotin catabolism accelerates significantly during pregnancy
- People with chronic alcohol use, which impairs biotin absorption
- Those on long-term anticonvulsant medications, particularly valproic acid
- People eating large quantities of raw egg white, which contains avidin, a protein that binds biotin and blocks its absorption
Outside these groups, most adults in the UK eating a reasonably varied diet are unlikely to be biotin deficient. Thompson et al. (2021) reviewed the dermatology evidence for biotin alongside zinc, vitamin D, and nicotinamide, and concluded that biotin supplementation in the absence of deficiency lacks strong trial support for hair or skin outcomes. That's a fair summary of where the science sits.
That said, and I want to be careful not to overstate this, subclinical insufficiency may be more common than the textbooks suggest. The Trüeb (2016) finding of 38% low biotin prevalence in women with hair loss complaints is worth sitting with. These weren't patients with obvious deficiency risk factors. They were women presenting at a hair loss clinic with no obvious metabolic cause identified.
The supplement market reality: hype versus data
Biotin is everywhere in the UK supplement market. Walk into any Holland & Barrett or scroll through Instagram and you'll find 5,000 mcg, 10,000 mcg, even 30,000 mcg biotin supplements marketed for "luscious hair" and "glowing skin." The marketing language is extraordinary. The evidence behind it, less so.
Zamil et al. (2023) analysed skin, hair, and nail supplements advertised on Instagram and found that the majority made claims that were unsupported by clinical evidence, with biotin being among the most frequently overstated ingredients. The gap between marketing claims and published data was, in their words, substantial.
Trepanowski et al. (2023) used NHANES data to track trends in hair, skin, and nail supplement use in the US and found that biotin was the most commonly used single ingredient in this category, despite the authors noting that evidence for efficacy in non-deficient populations remains limited. The pattern in the UK market is broadly similar.
I find this frustrating. Not because biotin is useless, it isn't, and the authorised claim is real, but because the megadose marketing creates unrealistic expectations and obscures the more nuanced story about who actually stands to benefit.
Biotin, isotretinoin, and skin integrity
One area where I think biotin warrants more attention is in the context of isotretinoin (Roaccutane) use. Isotretinoin is the gold-standard treatment for severe acne, but it has well-documented effects on skin barrier function and hair cycling. Aksac et al. (2021) evaluated biophysical skin parameters and hair changes in acne patients on isotretinoin and found significant changes in skin hydration and hair shaft characteristics over the treatment course.
Biotin's role in fatty acid synthesis, and therefore in skin lipid production, makes it a biologically plausible support nutrient during isotretinoin treatment, though the direct clinical evidence for this specific application is thin. It's mechanistic reasoning, not a proven intervention. Anyone on isotretinoin should be working with their dermatologist, not self-supplementing based on a blog post.
Biotin and the broader micronutrient picture
Hair and skin health don't live in a single-nutrient vacuum. Biotin gets most of the attention, but zinc, for instance, plays a direct role in keratinocyte function and sebum regulation. I've written about this in detail, the piece on zinc the mineral most men are subtly deficient in covers how widespread low zinc status is and what the evidence says about supplementation.
There's also an emerging body of work on multi-ingredient approaches. Piquero-Casals et al. (2026) studied oral supplementation combining l-cystine with several botanical extracts in chronic telogen effluvium, a form of diffuse hair shedding, and found meaningful reductions in hair loss over a 6-month period. Biotin was part of the formulation. Isolating biotin's individual contribution from a multi-ingredient study is difficult, but the direction of effect is consistent with the deficiency-correction hypothesis.
Similarly, Patel et al. (2025) looked at plant-derived biotin alongside silica extracts and found some evidence of positive effects on hair and skin parameters, though the study was small and the biotin source was non-standard, so I'd treat those findings cautiously.
For what it's worth, I've also found that some of the most evidence-supported ingredients for cardiovascular and metabolic health, like those discussed in the piece on aged garlic extract benefits, have downstream effects on circulation that may support peripheral tissue health, including scalp perfusion. That's speculative extrapolation, but it's the kind of systems thinking I find useful when building a daily formula.
What a collagen trial tells us about the evidence standard
Trehan et al. (2024) ran a placebo-controlled trial of a collagen supplement on skin and hair matrix in healthy adults. I mention it here not because it's a biotin study, it isn't, but because it illustrates what a properly designed trial in this space looks like: randomised, placebo-controlled, with objective biophysical measurements of skin hydration, elasticity, and hair tensile strength as endpoints. The biotin literature has almost none of this. That's the honest state of play.
Frequently asked questions
Does biotin actually work for hair loss in the UK?
The evidence suggests biotin may help restore normal hair in people with low biotin status, but there's no published RCT showing regrowth in otherwise replete adults. Patel et al. (2020) reviewed 18 cases and found positive outcomes only where an underlying deficiency or metabolic cause was present.
How much biotin should I take for skin and hair?
The UK RNI is around 30, 40 mcg/day. A dose of 100 mcg covers likely dietary shortfalls without approaching the high doses linked to laboratory test interference. Megadose products (5,000, 10,000 mcg) are not supported by evidence in non-deficient adults, as noted by Shing et al. (2025).
Can too much biotin cause problems?
At very high doses, typically above 5,000 mcg/day, biotin may interfere with biotin-streptavidin-based laboratory assays, including troponin and thyroid tests. Shing et al. (2025) flagged this as a clinically relevant concern in older adults. At physiological doses around 100 mcg, there's no known safety issue.
Is biotin deficiency common in the UK?
Overt deficiency is uncommon in people eating a varied diet. However, Trüeb (2016) found low serum biotin in 38% of women presenting with hair loss, many without obvious dietary risk factors, suggesting subclinical insufficiency may be more prevalent than assumed.
Are the biotin supplements marketed on Instagram worth buying?
Most make claims that go well beyond the published evidence. Zamil et al. (2023) found that biotin was among the most frequently overstated ingredients in social media supplement advertising. The authorised claim, that biotin contributes to the maintenance of normal hair and skin, is real, but it's narrower than the marketing implies.
Does the form of biotin matter, D-Biotin versus standard biotin?
D-Biotin is the naturally occurring, biologically active enantiomer. Supplements labelled simply "biotin" typically contain D-Biotin anyway, but it's worth confirming on the label. The research reviewed by Thompson et al. (2021) used D-Biotin forms throughout, which is the form with the established physiological role.
My honest take
I'll be candid: when I was formulating KōJō's daily supplement, biotin was one of the easier decisions, not because I think it's a dramatic ingredient, but because the authorised claim is solid, the safety profile is excellent, and the cost of inclusion is negligible. Including 100 mcg of D-Biotin to cover potential dietary shortfalls is, to my mind, just sensible insurance.
What I'm less comfortable with is the broader narrative around biotin in the UK supplement market. I've seen products containing 30,000 mcg, that's 30 mg, marketed as the answer to hair thinning. The evidence doesn't support that. If anything, I think the megadose biotin trend has done the ingredient a disservice by creating expectations it can't meet in most people, which then leads to dismissal of a nutrient that does have a legitimate physiological role.
If I were advising someone dealing with noticeable hair shedding or skin changes, my honest first suggestion would be to get serum biotin measured before spending money on supplements. That data point would tell you far more than any amount of reading. If your levels are low, supplementing makes sense. If they're normal, biotin probably isn't the lever you need to pull, and the time might be better spent looking at zinc, iron, or thyroid function instead.
The biology here is real. The claim is authorised. The evidence for benefit in deficient individuals is consistent. People deserve a more honest account of where the evidence ends and the marketing begins.
This article is for informational purposes only and does not constitute medical advice. Consult your healthcare provider before starting any supplement regimen.
References (11 studies)
- Patel et al. (2020), A Review of the Use of Biotin for Hair Loss. PMID 28879195
- Lipner (2018), Rethinking biotin therapy for hair, nail, and skin disorders. PMID 29438761
- Trüeb (2016), Serum Biotin Levels in Women Complaining of Hair Loss. PMID 27601860
- Thompson et al. (2021), Dietary supplements in dermatology: A review of the evidence for zinc, biotin, vitamin D, nicotinamide, and Polypodium leucotomos. PMID 32360756
- Trepanowski et al. (2023), Trends in Hair, Skin, and Nails Supplement Use: Data from NHANES. PMID 37348562
- Aksac et al. (2021), Evaluation of biophysical skin parameters and hair changes in patients with acne vulgaris treated with isotretinoin. PMID 33682085
- Piquero-Casals et al. (2026), Oral Supplementation with l-Cystine, Serenoa repens, Cucurbita pepo, and Pygeum africanum in Chronic Telogen Effluvium. PMID 39911983
- Shing et al. (2025), Benefits and risks of hair, skin, and nail supplements in older adults. PMID 41278416
- Patel et al. (2025), The Role of Sesbania grandiflora-Derived Biotin and Bambusa arundinacea-Derived Silica Extracts in Promoting Hair, Skin, and Nail Health. PMID 40896024
- Zamil et al. (2023), Skin, hair, and nail supplements advertised on Instagram. PMID 36578583
- Trehan et al. (2024), Efficacy and Safety of Skin Radiance Collagen on Skin and Hair Matrix: A Placebo-Controlled Clinical Trial in Healthy Humans. PMID 38495912
Photo via Unsplash
